Skip to main content
COR logo

COR · Cencora, Inc.

Track COR — free
$318.04 +3.35 (+1.06%) At close · Aug 21
Market Cap
$60.69B
Shares
190.83M

Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Recent news

Date Headline
2026-08-05 Cencora Reports Fiscal 2026 Third Quarter Results
2026-07-01 Cencora Announces Date and Time for Third Quarter Fiscal 2026 Earnings Release
2026-06-15 Cencora Announces Samantha Hammock as Chief Human Resources Officer
2026-05-27 Cencora Appoints Eva Boratto as Executive Vice President and Chief Financial Officer
2026-05-21 Cencora Announces Updated Fiscal Year 2026 Financial Outlook
2026-05-06 Cencora Reports Fiscal 2026 Second Quarter Results
2026-04-01 Cencora Announces Date and Time for Second Quarter Fiscal 2026 Earnings Release
2026-03-23 Cencora to Expand Retina Consultants of America Through Acquisition of EyeSouth Partners’ Retina Business
2026-03-17 Cencora Announces Financial Leadership Transition
2026-02-18 Covetrus and MWI Animal Health to Merge
2026-02-13 Cencora Closes $3.0 Billion Senior Notes Offering
2026-02-10 Cencora Prices $500 Million 3.950% Senior Notes Due 2029, $500 Million 4.250% Senior Notes Due 2030, $500 Million 4.600% Senior Notes Due 2033, $1.0 Billion 4.900% Senior Notes Due 2036 and $500 Million 5.650% Senior Notes Due 2056
2026-02-04 Cencora Reports Fiscal 2026 First Quarter Results

Revenue of $85.9 billion for the First Quarter, a 5.5% Increase Year-Over-Year First Quarter GAAP Diluted EPS of $2.87 and Adjusted Diluted EPS of $4.08 Adjusted Operating Income Guidance Raised to Growth of 11.5% to 13.5% Adjusted Diluted EPS Guidance Range Reaffirmed at $17.45 to $17.75 for Fiscal 2026 Company Completes Acquisition of OneOncology Cencora, Inc. (NYSE: COR) reported that in its fiscal year 2026 first quarter ended December 31, 2025, revenue increased 5.5 percent year-over-year to $85.9 billion. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (EPS) was $2.87 for the first quarter of fiscal 2026 compared to $2.50 in the prior year first quarter. Adjusted diluted EPS, which is a non-GAAP financial measure that excludes items described below, increased 9.4 percent to $4.08 in the fiscal first quarter from $3.73 in the prior year first quarter. Cencora is updating its outlook for fiscal year 2026. The Company

2026-01-22 Cencora Elects Ellen Cooper to Its Board of Directors

Cencora, Inc. (NYSE: COR) today announced that its Board of Directors has elected Ellen Cooper as a new independent director, effective January 20, 2026. Ms. Cooper is the Chairman, President and Chief Executive Officer of Lincoln Financial. Prior to assuming the role of CEO in May 2022, she served as Executive Vice President, Chief Investment Officer, Head of Enterprise Risk and Annuity Solutions. Prior to joining Lincoln, Ms. Cooper was with Goldman Sachs Asset Management, where she served as Managing Director and Global Head of Insurance Strategy. Earlier in her career, she was the Chief Risk Officer for AEGON Americas and a Principal at Ernst & Young LLP. “Ellen’s expertise in risk management and experience as a leader in a regulated and complex industry will build upon the Board’s ability to continue to support Cencora’s long-term sustainable growth. Her appointment underscores the Board’s ongoing focus on enhancing its breadth and depth to guide the company into the future,”

2026-01-06 Cencora Announces Date and Time for First Quarter Fiscal 2026 Earnings Release

Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the First Quarter of Fiscal 2026 on Wednesday, February 4, 2026, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on February 4, 2026. Participating in the conference call will be: Robert P. Mauch, President & Chief Executive Officer James F. Cleary, Executive Vice President & Chief Financial Officer The live call will be webcast via the Company’s website at investor.cencora.com . Users are encouraged to log on to the webcast approximately 10 minutes in advance of the scheduled start time of the call. To access the call via telephone from within the United States and Canada, dial +1 (833) 470-1428. From outside the United States and Canada, dial +1 (646) 844-6383. The access code for the call will be 909212. Replays of the call will be made available via telephone and webcast. A replay of

Past events

Date Event Type
2026-08-05 Cencora, Inc. Q3 FY26 Earnings Call Earnings call
2026-05-13 BofA Securities 2026 Health Care Conference Conference
2026-05-06 Cencora, Inc. Q2 FY26 Earnings Call Earnings call
2026-03-10 Leerink Partners Global Healthcare Conference Conference
2026-03-10 Barclays Global Healthcare Conference Conference
2026-02-04 Cencora, Inc. Q1 FY26 Earnings Call Earnings call
2026-01-12 Cencora at 44th Annual J.P. Morgan Healthcare Conference Conference
2025-12-02 Citi Global Healthcare Conference Conference
2025-12-02 Evercore Healthcare Conference Conference
2025-11-05 Cencora, Inc. Q4 FY25 Earnings Call Earnings call
2025-09-10 Morgan Stanley Healthcare Conference Conference
2025-09-09 Baird Healthcare Conference Conference
2025-09-05 Wells Fargo Healthcare Conference Conference
2025-08-06 Cencora, Inc. Q3 FY25 Earnings Call Earnings call
2025-05-13 BofA Securities 2025 Health Care Conference Conference
2025-05-07 Cencora, Inc. Q2 FY25 Earnings Call Earnings call
2025-03-10 Leerink Partners Global Healthcare Conference Conference
2025-02-05 Cencora, Inc. Q1 FY25 Earnings Call Earnings call
2025-01-13 Cencora at 43rd Annual J.P. Morgan Healthcare Conference Conference
2024-12-05 Evercore HealthCONx Conference Conference
2024-12-04 Citi Global Healthcare Conference Conference
2024-11-06 Cencora, Inc. Q4 FY24 Earnings Call Earnings call
2024-09-11 Baird Healthcare Conference Conference
2024-09-06 Wells Fargo Healthcare Conference Conference
2024-09-05 Morgan Stanley Healthcare Conference Conference

Source: https://investor.cencora.com/overview/default.aspx

Key facts CIK 1140859 CUSIP 03073E105 13F (30d) 1043 filings 1005 filers Visit website Investor relations